Teva Pharmaceutical Industries Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0006290147
ILS
92.87
3.67 (4.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
15,366.39
15,032.52
15,066.26
13,960.14
15,533.86
16,117.77
15,504.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15,366.39
15,032.52
15,066.26
13,960.14
15,533.86
16,117.77
15,504.59
Raw Material Cost
6,686.41
7,316.21
7,425.72
7,276.33
7,807.65
8,105.30
7,972.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
702.46
796.85
1,013.25
1,036.89
525.69
1,024.76
797.21
Selling and Distribution Expenses
3,642.40
3,271.45
3,433.59
3,320.23
3,524.36
3,430.73
3,498.03
Other Expenses
16.59
6.39
-13.96
-14.45
39.24
-13.37
20.49
Total Expenditure (Excl Depreciation)
11,197.14
11,448.39
11,732.93
11,488.94
12,250.13
12,427.13
12,472.22
Operating Profit (PBDIT) excl Other Income
4169.3
3584.1000000000004
3333.2999999999997
2471.2
3283.7
3690.6
3032.4
Other Income
-9.76
-30.26
-17.90
-10.84
-37.02
74.26
3.73
Operating Profit (PBDIT)
5,005.05
4,391.07
4,214.11
3,341.91
4,242.57
4,726.54
4,000.95
Interest
702.46
796.85
1,013.25
1,036.89
525.69
1,024.76
797.21
Exceptional Items
-3,196.86
-588.39
-1,575.37
-357.67
-3,635.43
-3,928.27
-3,159.03
Gross Profit (PBDT)
8,679.98
7,716.31
7,640.54
6,683.82
7,726.21
8,012.47
7,532.51
Depreciation
845.56
837.19
898.68
881.54
995.86
961.65
964.85
Profit Before Tax
260.17
2,172.00
726.82
1,062.18
-914.41
-1,202.98
-916.42
Tax
-1,265.08
719.52
-279.27
267.35
107.36
256.19
2,346.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,561.03
1,455.84
1,009.67
773.15
-803.35
-1,622.54
-3,147.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,561.03
1,455.84
1,009.67
773.15
-803.35
-1,622.54
-3,147.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
3.36
0.00
21.68
-214.72
174.51
-108.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,561.03
1,459.21
1,009.67
794.83
-1,018.07
-1,448.04
-3,255.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
25,209.96
23,950.38
22,989.92
23,338.16
19,577.33
22,559.98
23,955.62
Earnings per share (EPS)
1.33
1.25
0.87
0.67
-0.71
-1.43
-2.78
Diluted Earnings per share
1.33
1.25
0.87
0.67
-0.71
-1.43
-2.78
Operating Profit Margin (Excl OI)
27.13%
23.84%
22.12%
17.7%
21.14%
22.9%
19.56%
Gross Profit Margin
7.2%
20.02%
10.79%
13.92%
0.52%
-1.5%
0.31%
PAT Margin
10.16%
9.68%
6.7%
5.54%
-5.17%
-10.07%
-20.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.22% vs -0.22% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 6.98% vs 44.52% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 13.42% vs 4.47% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -11.83% vs -21.36% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Teva Pharmaceutical Industries Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(ILS)
Change(%)
Net Sales
15,366.39
0
15,366.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
15,366.39
0
15,366.39
Raw Material Cost
6,686.41
0
6,686.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
702.46
0
702.46
Selling and Distribution Expenses
3,642.40
0
3,642.40
Other Expenses
16.59
0.00
16.59
Total Expenditure (Excl Depreciation)
11,197.14
0
11,197.14
Operating Profit (PBDIT) excl Other Income
4,169.25
0.00
4,169.25
Other Income
-9.76
0
-9.76
Operating Profit (PBDIT)
5,005.05
0
5,005.05
Interest
702.46
0
702.46
Exceptional Items
-3,196.86
0
-3,196.86
Gross Profit (PBDT)
8,679.98
0
8,679.98
Depreciation
845.56
0
845.56
Profit Before Tax
260.17
0
260.17
Tax
-1,265.08
0
-1,265.08
Provisions and contingencies
0
0
0.00
Profit After Tax
1,561.03
0
1,561.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,561.03
0
1,561.03
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,561.03
0
1,561.03
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
25,209.96
0
25,209.96
Earnings per share (EPS)
1.33
0
1.33
Diluted Earnings per share
1.33
0
1.33
Operating Profit Margin (Excl OI)
27.13%
0%
0.00
27.13%
Gross Profit Margin
7.20%
0%
0.00
7.20%
PAT Margin
10.16%
0%
0.00
10.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,536.64 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.22% vs -0.22% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -1.08% vs -9.26% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 156.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.98% vs 44.52% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 253.32% vs -157.16% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 501.48 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 13.42% vs 4.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 17.18% vs -28.95% in Dec 2024

Quarterly - Interest
Interest 70.25 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -11.83% vs -21.36% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 33.63% vs -42.93% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.13%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024